Operating Income (Annual)

Operating Income: The income after operating expenses.

Dolby Laboratories (DLB) had Operating Income of $264.96M for the most recently reported fiscal year, ending 2025-09-30.

Quarterly Annual

Figures for fiscal year ending 2025-09-30

Income Statement Financials
Revenue	$1.35B
Net Income	$255.02M
Cost of Goods Sold	$160.13M
Gross Profit	$1.19B
Operating Expenses	$1.08B
Operating Income	$264.96M
Non-Operating Income/Expense	$38.53M
Pre-Tax Income	$303.49M
Normalized Pre-Tax Income	$303.49M
Income after Taxes	$256.49M
Income from Continuous Operations	$256.49M
Consolidated Net Income/Loss	$256.49M
Normalized Income after Taxes	$256.49M
EBIT	$264.96M
EBITDA	$363.56M
Weighted-Average Shares Outstanding (Basic)	95.87M
Weighted-Average Shares Outstanding (Diluted)	97.48M
Earnings per Share (EPS) (Basic)	$2.66
Earnings per Share (EPS) (Diluted)	$2.62
Balance Sheet Financials
Current Assets	$1.39B
Property, Plant, and Equipment	$470.61M
Long-Term Assets	$1.84B
Total Assets	$3.23B
Current Liabilities	$437.79M
Long-Term Debt	--
Long-Term Liabilities	$158.02M
Total Liabilities	$595.81M
Common Equity	$2.63B
Tangible Shareholders Equity	$1.70B
Shareholders Equity	$2.63B
Common Shares Outstanding	95.46M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$472.20M
Cash Flow from Investing Activities	$-10.59M
Cash Flow from Financial Activities	$-247.24M
Beginning Cash	$577.75M
End Cash	$793.36M
Increase/Decrease in Cash	$215.61M
Stock-Based Compensation	$128.51M
Common Stock Dividends Paid	$-126.60M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.17
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	--
Debt to Equity Ratio	--
Gross Margin	88.13%
Operating Margin	19.64%
EBIT Margin	19.64%
EBITDA Margin	26.95%
Pre-Tax Profit Margin	22.49%
Profit Margin	18.90%
Free Cash Flow	$435.85M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.42
Inventory Turnover	5.26
Receiveable Turnover	4.07
Days Sales in Receivables	89.58
Return on Equity	9.75%
Return on Tangible Equity	15.04%
Return on Assets	7.95%
Return on Investments	9.75%
Book Value Per Share	$27.57
Free Cash Flow per Share	$4.47
Operating Cash Flow per Share	$4.84

Data from Zacks Investment Research, Inc.